Spectrum Pharmaceuticals Inc - Net Worth and Insider Trading
Spectrum Pharmaceuticals Inc Net Worth
The estimated net worth of Spectrum Pharmaceuticals Inc is at least $6 Million dollars as of 2024-11-13. Spectrum Pharmaceuticals Inc is the 10% Owner of CASI Pharmaceuticals Inc and owns about 1,154,768 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $6 Million. Details can be seen in Spectrum Pharmaceuticals Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Spectrum Pharmaceuticals Inc has not made any transactions after 2017-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Spectrum Pharmaceuticals Inc
Spectrum Pharmaceuticals Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Spectrum Pharmaceuticals Inc owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .
Click here to see the complete history of Spectrum Pharmaceuticals Inc’s form 4 insider trades.
Insider Ownership Summary of Spectrum Pharmaceuticals Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2017-12-22 | 10 percent owner |
Spectrum Pharmaceuticals Inc Latest Holdings Summary
Spectrum Pharmaceuticals Inc currently owns a total of 1 stock. Spectrum Pharmaceuticals Inc owns 1,154,768 shares of CASI Pharmaceuticals Inc (CASI) as of December 22, 2017, with a value of $6 Million.
Latest Holdings of Spectrum Pharmaceuticals Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2017-12-22 | 1,154,768 | 5.60 | 6,466,701 |
Holding Weightings of Spectrum Pharmaceuticals Inc
Spectrum Pharmaceuticals Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Spectrum Pharmaceuticals Inc has made a total of 0 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 151,910 shares on December 22, 2017, which cost Spectrum Pharmaceuticals Inc around $15,191.
Insider Trading History of Spectrum Pharmaceuticals Inc
- 1
Spectrum Pharmaceuticals Inc Trading Performance
GuruFocus tracks the stock performance after each of Spectrum Pharmaceuticals Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Spectrum Pharmaceuticals Inc is 23.01%. GuruFocus also compares Spectrum Pharmaceuticals Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Spectrum Pharmaceuticals Inc within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Spectrum Pharmaceuticals Inc's insider trading performs compared to the benchmark.
Performance of Spectrum Pharmaceuticals Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.43 | | | | | |
| Relative Return to S&P 500(%) | 24.68 | | | | | |
Spectrum Pharmaceuticals Inc Ownership Network
Ownership Network List of Spectrum Pharmaceuticals Inc
Ownership Network Relation of Spectrum Pharmaceuticals Inc
Spectrum Pharmaceuticals Inc Owned Company Details
What does CASI Pharmaceuticals Inc do?
Who are the key executives at CASI Pharmaceuticals Inc?
Spectrum Pharmaceuticals Inc is the 10 percent owner of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .
CASI Pharmaceuticals Inc (CASI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.
CASI Pharmaceuticals Inc Insider Transactions
Spectrum Pharmaceuticals Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Spectrum Pharmaceuticals Inc. You might contact Spectrum Pharmaceuticals Inc via mailing address: 11500 S. Eastern Ave., Suite 240, Henderson Nv 89052.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
